Minor injection site reactions Temporary nausea at higher doses Slight sleep changes with evening dosing Mild headache during initial days Dizziness or lightheadedness Increased appetite Fatigue during loading phase Minor digestive changes Significant swelling or rash Persistent breathing changes Severe headache or vision changes Any concerning symptoms The peptides mechanism profile suggests certain theoretical concerns worth acknowledging
hunger is often greatest during the early titration phase
In December 2023, the FDA issued a warning about compounded semaglutide products, noting that some contained salt forms of semaglutide (such as semaglutide sodium or semaglutide acetate) that differ from the base form in the FDA-approved products
Under IRS guidance, prescription medications and medical services ordered by licensed providers are generally eligible expenses
Kannt A, Rajagopal S, Kadnur SV, et al
We will evaluate your dosage and your results monthly to help you reach your goals